Saturday, 27 February 2021

LIVE Video

Kavin Kumar Kandasamy, Founder and Chief Executive Officer, MY, Coimbatore
Videos

Inside Magazine
INDIAN BIOPHARMA HITS RS 25,000 CRORE RIDING 15% GROWTH WAVE  

The Indian Biopharma Industry, with over 300 companies, is growing at the rate of 15 per cent, which is 3 per cent more than the previous year’s 12 per cent. This growth was largely driven by over 20 per cent growth rate recorded by 8 of the top 20 companies in the biopharma space. As a result, the Indian Biopharma Industry has crossed the Rs 25,000 crore mark for the year 2019-20 over the previous year’s figure of Rs 22,124 crore. In 2017-18 the industry recorded a revenue of Rs 18,290 crore. The Indian Biopharma industry, comprising hormones, insulin, blood products and vaccines recorded a sales revenue of Rs 25,442 crore for the year 2019-20.    
 
For Feedback, please email us at : communications@mmactiv.com
--

Sign up here to access BioSpectrum India Flip Book.

BioSpectrum Infomercial